EXELIXIS, INC. (EXEL) reporting calendar
EXELIXIS, INC. files periodic reports with the SEC as EXEL on Nasdaq. Atlas tracks 34 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 31 Jul 2026 – 14 Aug 2026
- Latest report
- 10-Q
- Period ended
- 3 Apr 2026
- Filed
- 5 May 2026
- Reports on record
- 34
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 35 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open EXEL market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 3 Apr 2026 | 5 May 2026 | 32 days | 0000939767-26-000059 |
| 10-K | 2 Jan 2026 | 10 Feb 2026 | 39 days | 0000939767-26-000021 |
| 10-Q | 3 Oct 2025 | 4 Nov 2025 | 32 days | 0000939767-25-000128 |
| 10-Q | 4 Jul 2025 | 28 Jul 2025 | 24 days | 0000939767-25-000113 |
| 10-Q | 4 Apr 2025 | 13 May 2025 | 39 days | 0000939767-25-000075 |
| 10-K | 3 Jan 2025 | 11 Feb 2025 | 39 days | 0000939767-25-000019 |
| 10-Q | 27 Sep 2024 | 29 Oct 2024 | 32 days | 0000939767-24-000150 |
| 10-Q | 28 Jun 2024 | 6 Aug 2024 | 39 days | 0000939767-24-000119 |
| 10-Q | 29 Mar 2024 | 30 Apr 2024 | 32 days | 0000939767-24-000058 |
| 10-K | 29 Dec 2023 | 6 Feb 2024 | 39 days | 0000939767-24-000028 |
| 10-Q | 29 Sep 2023 | 1 Nov 2023 | 33 days | 0000939767-23-000114 |
| 10-Q | 30 Jun 2023 | 1 Aug 2023 | 32 days | 0000939767-23-000079 |
| 10-Q | 31 Mar 2023 | 9 May 2023 | 39 days | 0000939767-23-000048 |
| 10-K | 30 Dec 2022 | 7 Feb 2023 | 39 days | 0000939767-23-000019 |
| 10-Q | 30 Sep 2022 | 1 Nov 2022 | 32 days | 0000939767-22-000110 |
| 10-Q | 1 Jul 2022 | 9 Aug 2022 | 39 days | 0000939767-22-000097 |
| 10-Q | 1 Apr 2022 | 10 May 2022 | 39 days | 0000939767-22-000058 |
| 10-K | 31 Dec 2021 | 18 Feb 2022 | 49 days | 0000939767-22-000026 |
| 10-Q | 1 Oct 2021 | 2 Nov 2021 | 32 days | 0000939767-21-000097 |
| 10-Q | 2 Jul 2021 | 5 Aug 2021 | 34 days | 0000939767-21-000076 |
| 10-Q | 2 Apr 2021 | 6 May 2021 | 34 days | 0000939767-21-000045 |
| 10-K | 1 Jan 2021 | 11 Feb 2021 | 41 days | 0001628280-21-001852 |
| 10-Q | 2 Oct 2020 | 5 Nov 2020 | 34 days | 0000939767-20-000150 |
| 10-Q | 3 Jul 2020 | 6 Aug 2020 | 34 days | 0000939767-20-000117 |
| 10-Q | 3 Apr 2020 | 5 May 2020 | 32 days | 0000939767-20-000068 |
| 10-K | 3 Jan 2020 | 25 Feb 2020 | 53 days | 0000939767-20-000035 |
| 10-Q | 27 Sep 2019 | 30 Oct 2019 | 33 days | 0000939767-19-000190 |
| 10-Q | 28 Jun 2019 | 31 Jul 2019 | 33 days | 0000939767-19-000157 |
| 10-Q | 29 Mar 2019 | 1 May 2019 | 33 days | 0000939767-19-000109 |
| 10-K | 28 Dec 2018 | 22 Feb 2019 | 56 days | 0000939767-19-000042 |
| 10-Q | 28 Sep 2018 | 1 Nov 2018 | 34 days | 0000939767-18-000218 |
| 10-Q | 29 Jun 2018 | 1 Aug 2018 | 33 days | 0000939767-18-000136 |
| 10-Q | 30 Mar 2018 | 2 May 2018 | 33 days | 0000939767-18-000069 |
| 10-K | 29 Dec 2017 | 26 Feb 2018 | 59 days | 0000939767-18-000023 |
Source: SEC EDGAR company submissions for CIK 0000939767. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.